Last reviewed · How we verify

NCT04352868

Customizing Myopia Control With Multifocal Toric Contact Lens

Withdrawn NA Last updated 9 November 2020
What this trial tests

NA trial testing Intelliwave multifocal, toric, soft contact lens in Refractive Errors. Withdrawn.

Timeline
1 September 2020
Primary endpoint
1 September 2021
1 September 2022

Quick facts

Lead sponsorUniversity of Alabama at Birmingham
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Start date1 September 2020
Primary completion1 September 2021
Estimated completion1 September 2022

Drugs / interventions tested

Conditions studied

Sponsor

University of Alabama at Birmingham

Who can join

Adults 8 to 12, any sex, with Refractive Errors or Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will evaluate the ability of toric multifocal contact lens to reduce the change of myopia progression in children (aged 8-12) with myopic astigmatism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Refractive Errors

Currently open trials in the same condition.

Other University of Alabama at Birmingham trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04352868.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing